EP174: Real World Data vs Real World Evidence, Especially for Pharma, With Julie Locklear From Genesis Research

Julie is an executive pharmaceutical leader with over 20 years of experience across all phases of development both on the commercial and research sides of the organization. She leverages her Masters in Business Administration and Doctorate of Pharmacy to develop and deliver strategic patient-centric value propositions to optimize patient access and improve outcomes in patients with difficult to treat diseases leading to longer, healthier, and more productive lives. Her years of experience in global and US payer markets provides Julie with intimate knowledge of the current and evolving payer and market access landscape in the United States and around the globe. She has led the development and execution of several outcomes-based contracts with 3 of the largest national payer organizations in the US.
Julie is well published, having authored more than 30 publications in peer-reviewed journals and more than 60 peer-reviewed abstracts presented as posters at major scientific congresses.